It may be possible to diagnose depression using more than just a patient’s behavioral symptoms. New findings suggest that people with major depressive disorder (MDD) have lower levels of the molecule acetyl-L-carnitine (LAC) in their blood than healthy controls. In addition, the degree of LAC deficiency reflects the severity and the age of onset of MDD—making LAC a tool that could transform depression diagnosis and treatment.